title: beta2-chimaerin is a novel target for diacylglycerol: binding properties and changes in subcellular localization mediated by ligand binding to its C1 domain.
abstract: The members of the chimaerin family of Rac-GTPase-activating proteins possess a single C1 domain with high homology to those present in protein kinase C (PKC) isozymes. This domain in PKCs is involved in phorbol ester and diacylglycerol (DAG) binding. We previously have demonstrated that one of the chimaerin isoforms, beta2-chimaerin, binds phorbol esters with high affinity. In this study we analyzed the properties of beta2-chimaerin as a DAG receptor by using a series of conformationally constrained cyclic DAG analogues (DAG lactones) as probes. We identified analogs that bind to beta2-chimaerin with more than 100-fold higher affinity than 1-oleoyl-2-acetylglycerol. The potencies of these analogs approach those of the potent phorbol ester tumor promoters. The different DAG lactones show some selectivity for this novel receptor compared with PKCalpha. Cellular studies revealed that these DAG analogs induce translocation of beta2-chimaerin from cytosolic (soluble) to particulate fractions. Using green fluorescent protein-fusion proteins for beta2-chimaerin we determined that this novel receptor translocates to the perinuclear region after treatment with DAG lactones. Binding and translocation were prevented by mutation of the conserved Cys-246 in the C1 domain. The structural homology between the C1 domain of beta2-chimaerin and the C1b domain of PKCdelta also was confirmed by modeling analysis. Our results demonstrate that beta2-chimaerin is a high affinity receptor for DAG through binding to its C1 domain and supports the emerging concept that multiple pathways transduce signaling through DAG and the phorbol esters.
authors.affiliation: Center for Experimental Therapeutics, Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6160, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Caloca
authors.forename: M L
authors.initials: ML
authors.lastname: Garcia-Bermejo
authors.forename: P M
authors.initials: PM
authors.lastname: Blumberg
authors.forename: N E
authors.initials: NE
authors.lastname: Lewin
authors.forename: E
authors.initials: E
authors.lastname: Kremmer
authors.forename: H
authors.initials: H
authors.lastname: Mischak
authors.forename: S
authors.initials: S
authors.lastname: Wang
authors.forename: K
authors.initials: K
authors.lastname: Nacro
authors.forename: B
authors.initials: B
authors.lastname: Bienfait
authors.forename: V E
authors.initials: VE
authors.lastname: Marquez
authors.forename: M G
authors.initials: MG
authors.lastname: Kazanietz
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001692:Biological Transport; D019556:COS Cells; D004075:Diglycerides / Q000378:metabolism*; D049452:Green Fluorescent Proteins; D007700:Kinetics; D007783:Lactones / Q000378:metabolism*; D008024:Ligands; D008164:Luminescent Proteins / Q000378:metabolism; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016296:Mutagenesis; D009363:Neoplasm Proteins / Q000378:metabolism*; D011485:Protein Binding; D011994:Recombinant Proteins / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D013997:Time Factors
chemical_list: D004075:Diglycerides; D007783:Lactones; D008024:Ligands; D008164:Luminescent Proteins; D009363:Neoplasm Proteins; D011994:Recombinant Proteins; C079844:beta-chimaerin; D049452:Green Fluorescent Proteins